H. Celik And E. Arinc, "Comparison of the in vitro DNA-damaging potential of the two anticancer drugs idarubicin and mitomycin C in the presence of NADPH-cytochrome P450 reductase," 9th European Meeting of the International-Society-for-the-Study-of-Xenobiotics (ISSX) , vol.38, Manchester, United Kingdom, pp.185-186, 2006
Celik, H. And Arinc, E. 2006. Comparison of the in vitro DNA-damaging potential of the two anticancer drugs idarubicin and mitomycin C in the presence of NADPH-cytochrome P450 reductase. 9th European Meeting of the International-Society-for-the-Study-of-Xenobiotics (ISSX) , (Manchester, United Kingdom), 185-186.
Celik, H., & Arinc, E., (2006). Comparison of the in vitro DNA-damaging potential of the two anticancer drugs idarubicin and mitomycin C in the presence of NADPH-cytochrome P450 reductase . 9th European Meeting of the International-Society-for-the-Study-of-Xenobiotics (ISSX) (pp.185-186). Manchester, United Kingdom
Celik, Haydar, And Emel Arinc. "Comparison of the in vitro DNA-damaging potential of the two anticancer drugs idarubicin and mitomycin C in the presence of NADPH-cytochrome P450 reductase," 9th European Meeting of the International-Society-for-the-Study-of-Xenobiotics (ISSX), Manchester, United Kingdom, 2006
Celik, Haydar And Arinc, Emel. "Comparison of the in vitro DNA-damaging potential of the two anticancer drugs idarubicin and mitomycin C in the presence of NADPH-cytochrome P450 reductase." 9th European Meeting of the International-Society-for-the-Study-of-Xenobiotics (ISSX) , Manchester, United Kingdom, pp.185-186, 2006
Celik, H. And Arinc, E. (2006) . "Comparison of the in vitro DNA-damaging potential of the two anticancer drugs idarubicin and mitomycin C in the presence of NADPH-cytochrome P450 reductase." 9th European Meeting of the International-Society-for-the-Study-of-Xenobiotics (ISSX) , Manchester, United Kingdom, pp.185-186.
@conferencepaper{conferencepaper, author={Haydar Celik And author={Emel Arinc}, title={Comparison of the in vitro DNA-damaging potential of the two anticancer drugs idarubicin and mitomycin C in the presence of NADPH-cytochrome P450 reductase}, congress name={9th European Meeting of the International-Society-for-the-Study-of-Xenobiotics (ISSX)}, city={Manchester}, country={United Kingdom}, year={2006}, pages={185-186} }